Download presentation
Presentation is loading. Please wait.
Published byHartanti Pranoto Modified over 6 years ago
1
Better access to, and use of, surveillance data
26th September 2016 Better access to, and use of, surveillance data Insert name of presentation on Master Slide Presenter: Robin Howe Chair T&F group 4
3
Total antibacterial usage by hospital: DDD/1000 BD (2015)
Insert name of presentation on Master Slide
4
Aims for T&FG4 Information for Action
Develop web access tool for availability of timely local antimicrobial resistance and usage information Requires reliable and timely feeds of usage data from NWIS Develop mechanisms to enable early detection of threats at local level. ICNet Resistance alert system Develop web tools to support annual and local point prevalence surveys. BSAC system (MS IE 9) Robin Howe - T&F group 4
5
Aims for T&FG4 Information for Action
Develop infrastructure to facilitate timely local information on antimicrobial usage. Audit+ e-Prescribing Develop health board reports that integrate antibiotic usage and resistance data to inform areas for action. Develop targeted surveillance of carbapenemase-producing bacteria. Integrate resistance alerts with laboratory testing Robin Howe - T&F group 4
6
Aims for T&FG4 Measuring success
Baseline and trends in resistance for key Drug/Bug combinations Available through DataStore Measuring the 50% reduction of inappropriate prescribing Link Prescribing with indication Primary care - Audit+ Secondary care - e-Prescribing, audit, PPS Measuring the 50% reduction in HA-GNBacteraemia Develop within ICNet Measuring “lack of harm” Robin Howe - T&F group 4
7
Engagement Public Health Wales NWIS AWMSG Chief Pharmacist Group
AWTTC AWPAG Chief Pharmacist Group AWAPG Health Boards & Trusts Robin Howe - T&F group 4
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.